CMH — Chordate Medical Holding AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK16.40m
- SEK13.87m
- SEK0.66m
Annual cashflow statement for Chordate Medical Holding AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19.8 | -21.8 | -27.9 | -29.2 | -27.3 |
| Non-Cash Items | 2.57 | 1.54 | 2.45 | 2.45 | 2.22 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.239 | -0.111 | 0.511 | -0.53 | 0.627 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -17.4 | -20.3 | -25 | -27.3 | -24.4 |
| Capital Expenditures | -2.99 | -1.3 | -0.389 | -1.15 | -2.88 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.129 | — | — | -0.009 | 0 |
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -3.12 | -1.3 | -0.389 | -1.16 | -2.88 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 32.5 | 35.1 | 0.065 | 33.2 | 21.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 12 | 13.4 | -25.3 | 4.78 | -5.93 |